Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
| Sales | 3,640 | 5,510 | 5,610 | 4,660 | 3,360 |
| Cost of Goods | 2,420 | 3,670 | 3,930 | 3,250 | 2,060 |
| Gross Profit | 1,220 | 1,840 | 1,680 | 1,410 | 1,300 |
| Operating Expenses | 0 | 430 | 0 | 0 | 0 |
| Operating Income | 1,220 | 1,410 | 1,680 | 1,410 | 1,300 |
| Interest Expense | 50 | -20 | 50 | 60 | 60 |
| Other Income | -1,120 | -1,000 | -1,150 | -1,240 | -1,130 |
| Pre-tax Income | 50 | 430 | 480 | 110 | 110 |
| Income Tax | 0 | 430 | 0 | 0 | 0 |
| Net Income Continuous | 50 | 0 | 480 | 110 | 110 |
| Net Income | $30 | $270 | $290 | $60 | $70 |
| EBITDA(a) | $1,220 | $1,410 | $1,680 | $1,410 | $1,300 |